Phentermine Over the Counter Alternative 2026 – OTC Appetite Suppressant Search Trend Analysis Positions PhenQ as a Market Leader According to 1200 Doctors 
Laguna Treatment Center Strengthens Clinical Team with New Behavioral Health Therapist
Behavioral Health Therapist Tanya L. Hauer, MSW, ACSW Laguna Treatment Center, a leading drug and alcohol rehab in Orange County,...
New Year, New Mission: Oxford Treatment Center Empowers Veterans to Reclaim Their Lives in 2026
ETTA, Miss., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Veterans face substance use disorders at disproportionately high rates. More than one...
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Saint-Herblain (France), Pune, (India), December 31, 2025 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum...
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
Company announcement – No. 27 / 2025 Total number of shares and voting rights in Zealand Pharma as of December...
BioNTX Marks the Close of the First Quarter of the 21st Century with Growth, Workforce Momentum, and Innovation Leadership
IRVING, Texas, Dec. 31, 2025 (GLOBE NEWSWIRE) -- As 2025 ends, BioNTX reflects on a year—and the close of the...
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement
Vancouver, Canada, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Black Book Recaps 2025 Research Announcements and Client‑Rated Honors; Reaffirms Vendor‑Agnostic, Independently Validated Intelligence and 2026 Commitments
In 2025, Black Book expanded global healthcare IT research coverage; issued 32 complimentary, vendor-neutral benchmarking reports; advanced a 36‑KPI qualitative...
Your Hospital Isn’t Just a Number: Reclaiming Local Autonomy in Rural Healthcare
WATKINSVILLE, GA / ACCESS Newswire / December 31, 2025 / In the world of hospital management, rural hospitals are too...
TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea
Expansion builds on newly granted South Korean patent, rising local demand and following the launch of digitally connected "VIVI Cap...
Izotropic Announces AGM Results
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - December 31, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
Hemostemix Closes $480,000 Private Placement at $0.12 per Share
Calgary, Alberta--(Newsfile Corp. - December 31, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (the "Company" or "Hemostemix"),...
Europe’s Health IT Upgrade Cycle Is Shifting to EHDS-Ready Interoperability, Localized User Experience, and Modular Modernization
Black Book Survey of 417 European health IT leaders across nine countries finds "interoperability-first" is now a procurement gate; multilingual...
Middle East Health IT Modernization Is Accelerating But Procurement Is Tightening Around Bilingual Operations, Sovereign Hosting, and Verifiable AI
Black Book Survey of health IT leaders across five high-activity Middle East markets finds sovereignty-compatible architectures and Arabic/English workflow readiness...
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"),...
Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins
Partnership with Syrma Johari Medtech, a globally recognized medical device engineering and manufacturing organization, expands INBS’ global manufacturing capacity, strengthens...
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued...
ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture...
Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent
Bagsværd, Denmark, 31 December 2025 – Today, the Supreme People’s Court in China made a positive decision concerning the intellectual...
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders
TARPON SPRINGS, Fla., December 31, 2025 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical...